LivaNova (LIVN) free cash flow

Free cash flow · fiscal 2025
$173.29M

LivaNova (LIVN) generated free cash flow of $173.29M in fiscal 2025 (the year ended December 31, 2025). That is 27.5% higher than the $135.93M of fiscal 2024. Figures as of 18 Nov 2026, 12:43 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Free cash flow, fiscal 2025
$173.29M
Change on fiscal 2024
+27.5%
Growth, 10 years
+9.0% a year
Highest on record
$173.29Mfiscal 2025
Lowest on record
-$115.83Mfiscal 2019
Fiscal years on record
132013–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

LivaNova free cash flow, in more detail

Over the ten fiscal years to 2025 free cash flow grew at a compound 9.0% a year. Across the 13 fiscal years on record (2013–2025), the highest was $173.29M in fiscal 2025 and the lowest -$115.83M in fiscal 2019.

History · 13 fiscal years

Free cash flow by fiscal year

LivaNova free cash flow, year by year

LivaNova (LIVN) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2025$173.29M 27.5% up
2024$135.93M 240.4% up
2023$39.93M 8.0% down
2022$43.40M 43.7% down
2021$77.07M—
2020-$114.45M—
2019-$115.83M 239.1% down
2018$83.30M 42.6% up
2017$58.41M 12.8% up
2016$51.79M 29.0% down
2015$72.99M 87.3% up
2014$38.97M 43.8% down
2013$69.35M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

Free cash flow at health care companies of similar size

Free cash flow of LivaNova and comparable companies
CompanyFree cash flowFiscal year
Edgewise Therapeutics EWTX-$144.07M2025
LivaNova LIVN$173.29M2025
Ionis Pharmaceuticals IONS-$325.67M2025
Dianthus Therapeutics DNTH-$129.27M2025
MiniMed Group MMED-$420.00M2026
Adaptive Biotechnologies ADPT-$48.95M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on LIVN

LivaNova, figure by figure

LivaNova (LIVN) overview: price, valuation and scorecardAll health care companies by market value

LivaNova free cash flow: questions and answers

What is LivaNova's free cash flow?

LivaNova (LIVN) generated free cash flow of $173.29M in fiscal 2025 (the year ended December 31, 2025). That is 27.5% higher than the $135.93M of fiscal 2024.

What is the growth rate of LivaNova's free cash flow?

Over the ten fiscal years to 2025 free cash flow grew at a compound 9.0% a year.

What are the highest and lowest free cash flow figures on record for LivaNova?

Across the 13 fiscal years on record (2013–2025), the highest was $173.29M in fiscal 2025 and the lowest -$115.83M in fiscal 2019.

How is LivaNova's free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For LivaNova it is on record here for 13 fiscal years, 2013 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “LivaNova (LIVN) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/LIVN/free-cash-flow

Underlying data: the company's filings with the SEC and Yahoo Finance.